GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » By-health Co Ltd (SZSE:300146) » Definitions » Research & Development

By-health Co (SZSE:300146) Research & Development : ¥182 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is By-health Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. By-health Co's Research & Development for the three months ended in Mar. 2024 was ¥31 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥182 Mil.


By-health Co Research & Development Historical Data

The historical data trend for By-health Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

By-health Co Research & Development Chart

By-health Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.04 139.95 150.30 158.50 179.33

By-health Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.26 52.39 42.76 55.93 31.40

By-health Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥182 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


By-health Co  (SZSE:300146) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


By-health Co Research & Development Related Terms

Thank you for viewing the detailed overview of By-health Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


By-health Co (SZSE:300146) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Xinghan Road, Sanzao Technology Industrial Park, Jinwan District, Guangdong Province, Zhuhai City, CHN, 510663
By-health Co Ltd, formerly Guangdong By-Health Biotechnology Co., Ltd. develops, produces and sells nutritional supplements, functional health food, and natural dietary supplement products to help people improve their health and quality of life.
Executives
Liang Shui Sheng Director
Chen Hong Executives
Tang Hui Director
Jiang Gang Supervisors
Lin Zhi Cheng Directors, executives
Cai Liang Ping Executives
Wang Wen Supervisors
Wu Zhen Yu Executives
Liang Yun Chao Director
Tang Jin Yin Securities Affairs Representative
Long Cui Yun Executives
Zhou Xu Ting Executives

By-health Co (SZSE:300146) Headlines

No Headlines